Clopidogrel (Plavix) will compete with prasugrel (Effient)

April 2008

Clopidogrel (Plavix) will compete with prasugrel (Effient) if it's approved...as early as this summer.

They're both in the same class...thienopyridines.

Prasugrel seems to be more effective than clopidogrel...for reducing cardiovascular events in some acute coronary syndrome patients undergoing angioplasty.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

new requirements for tamper-resistant Rxs
Cardiology growing evidence that calcium channel blockers may cause eczema and other skin problems
Cardiology Clopidogrel (Plavix) will compete with prasugrel (Effient)
Osteoporosis when to test bone density in MEN and when to treat osteopenia
Respiratory & Allergy Patients are hearing that Spiriva (tiotropium) might increase the risk of stroke
Respiratory & Allergy Many patients have trouble using dry powder inhalers
Women's Health Evamist is the first estradiol SPRAY for menopausal symptoms
Pediatrics Are children getting too high doses of amoxicillin?
Statins Do statins cause cognitive impairment?
Storage & Disposal Reports of trace amounts of pharmaceuticals in our water supply are getting a lot of press
Pregnancy which antihypertensives are safe to use during pregnancy
Psychiatry whether antidepressants are effective
Cholesterol Simcor, a new combination of simvastatin and Niaspan (extended-release niacin)

Clopidogrel (Plavix) will compete with prasugrel (Effient)

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents